By Brahadeesh Chandrasekaran, Healthcare Research Analyst, EIA
The introduction of implantable cardiac pacemaker and defibrillators has improved the quality of life and has reduced mortality and morbidity in millions of patients' worldwide suffering from cardiac diseases. These implantable devices have reduced the burden on physicians to continuously monitor the patients and also improved the patient safety. The implantable devices for treatment of cardiac rhythm management devices include; implantable cardiac pacemakers (pacemakers), implantable cardioverter defibrillators (ICD), and cardiac resynchronization therapy (CRT). The technological advancements in the field of electronics and communication technology together with increasing knowledge about human physiology has significantly increased the performance, safety and efficacy of these devices. Especially the advancements in the field of communication technology have opened up new possibilities to exchange information between the implants, external monitors and medical professionals or healthcare providers. This also eliminated the need for more frequent visits of patients for medical assessment.
Factors influencing the demand
The most important factor influencing the growth and increasing the demand for implantable cardiac devices is the demographic trends. The increasing ageing population and the increasing life expectancy rates in developed countries will increase the incidence and prevalence of cardiac related complications such as atrial fibrillation, heart failure etc.